← Back to Clinical Trials
Recruiting NCT07055945

NCT07055945 Investigation of the Effects of Visual-Motor Based Training on Upper Extremity Functions in Individuals With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07055945
Status Recruiting
Phase —
Sponsor Baskent University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2025-08-28
Primary Completion 2025-12-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Experimental groupControl group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2025-08-28 with a primary completion date of 2025-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to investigate the effects of visual-motor based training and physiotherapy program on upper extremity functions in individuals with stroke and to compare with physiotherapy program.

Eligibility Criteria

Inclusion criteria: * At least 6 months have passed since the cerebrovascular event * Aged between 18 and 75 years * First-time stroke * Scoring 24 or higher on the Standardized Mini Mental Test (SMMT) * Upper extremity functioning at Stage 4 or above according to the Brunnstrom Staging * Shoulder, elbow, wrist, and finger muscle tone at or below a score of 2 on the Modified ---Ashworth Scale (MAS) * Shoulder joint range of motion of at least 120° * Ability to stand independently Exclusion Criteria: * Presence of hemispatial neglect syndrome * Ataxia due to posterior circulatory ischemia * Bilateral involvement (bilateral hemiparesis) * Botulinum toxin injection in the last three months * Physiotherapy treatment within the last 6 months * Orthopedic problems such as shoulder subluxation, shoulder pain, or contractures in the hand or wrist * Previous upper extremity or thoracic surgery * Vision problems related to stroke (hemianopsia) * Color blindness

Contact & Investigator

Central Contact

Ayşegül Aykul, MSc

✉ aysegulaykul@hotmail.com

📞 +905444603250

Principal Investigator

Sevgi İkbali Afşar, Prof Dr

STUDY DIRECTOR

Baskent University

Frequently Asked Questions

Who can join the NCT07055945 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07055945 currently recruiting?

Yes, NCT07055945 is actively recruiting participants. Contact the research team at aysegulaykul@hotmail.com for enrollment information.

Where is the NCT07055945 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07055945 clinical trial?

NCT07055945 is sponsored by Baskent University. The principal investigator is Sevgi İkbali Afşar, Prof Dr at Baskent University. The trial plans to enroll 38 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology